AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
SEQUENCE-DEPENDENT HEMATOLOGICAL TOXICITY ASSOCIATED WITH THE 3-HOUR PACLITAXEL CYCLOPHOSPHAMIDE DOUBLET/
Authors: KENNEDY MJ ZAHURAK ML DONEHOWER RC NOE D GROCHOW LB SARTORIUS S CHEN TL BOWLING K DUERR M ROWINSKY EK
Citation: Mj. Kennedy et al., SEQUENCE-DEPENDENT HEMATOLOGICAL TOXICITY ASSOCIATED WITH THE 3-HOUR PACLITAXEL CYCLOPHOSPHAMIDE DOUBLET/, Clinical cancer research, 4(2), 1998, pp. 349-356
SEQUENCE-DEPENDENT HEMATOLOGICAL TOXICITY ASSOCIATED WITH THE 3-HOUR PACLITAXEL CYCLOPHOSPHAMIDE DOUBLET/
Authors: KENNEDY MJ ZAHURAK ML DONEHOWER RC NOE D GROCHOW LB SARTORIUS S CHEN TL BOWLING K DUERR M ROWINSKY EK
Citation: Mj. Kennedy et al., SEQUENCE-DEPENDENT HEMATOLOGICAL TOXICITY ASSOCIATED WITH THE 3-HOUR PACLITAXEL CYCLOPHOSPHAMIDE DOUBLET/, Clinical cancer research, 4(2), 1998, pp. 349-356
HIGH-DOSE TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN FLUOROPYRIMIDINE-REFRACTORY COLORECTAL-CANCER - A PHASE-II AND PHARMACODYNAMIC STUDY
Authors: ROWINSKY EK BAKER SD BURKS K OREILLY S DONEHOWER RC GROCHOW LB
Citation: Ek. Rowinsky et al., HIGH-DOSE TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN FLUOROPYRIMIDINE-REFRACTORY COLORECTAL-CANCER - A PHASE-II AND PHARMACODYNAMIC STUDY, Annals of oncology, 9(2), 1998, pp. 173-180
PRECLINICAL AND CLINICAL-PHARMACOLOGY OF MATRIX METALLOPROTEINASE INHIBITORS (MMPIS)
Authors: GROCHOW LB
Citation: Lb. Grochow, PRECLINICAL AND CLINICAL-PHARMACOLOGY OF MATRIX METALLOPROTEINASE INHIBITORS (MMPIS), Annals of oncology, 9, 1998, pp. 34-34
PRECLINICAL AND CLINICAL-PHARMACOLOGY OF MATRIX METALLOPROTEINASE INHIBITORS (MMPIS)
Authors: GROCHOW LB
Citation: Lb. Grochow, PRECLINICAL AND CLINICAL-PHARMACOLOGY OF MATRIX METALLOPROTEINASE INHIBITORS (MMPIS), Annals of oncology, 9, 1998, pp. 285-285
A PHASE-I AND PHARMACOLOGICAL STUDY OF DMP-840 ADMINISTERED BY 24-HOUR INFUSION
Authors: OREILLY S BAKER SD SARTORIUS S ROWINSKY EK FINIZIO M LUBINIECKI GM GROCHOW LB GRAY JE PIENIASZEK HJ DONEHOWER RC
Citation: S. Oreilly et al., A PHASE-I AND PHARMACOLOGICAL STUDY OF DMP-840 ADMINISTERED BY 24-HOUR INFUSION, Annals of oncology, 9(1), 1998, pp. 101-104
INCREASED 9-AMINOCAMPTOTHECIN DOSE REQUIREMENTS IN PATIENTS ON ANTICONVULSANTS
Authors: GROSSMAN SA HOCHBERG F FISHER J CHEN TL KIM L GREGORY R GROCHOW LB PIANTADOSI S
Citation: Sa. Grossman et al., INCREASED 9-AMINOCAMPTOTHECIN DOSE REQUIREMENTS IN PATIENTS ON ANTICONVULSANTS, Cancer chemotherapy and pharmacology, 42(2), 1998, pp. 118-126
CYTOTOXIC SYNERGY BETWEEN PYRAZOLOACRIDINE (NSC-366140) AND CISPLATININ-VITRO - INHIBITION OF PLATINUM-DNA ADDUCT REMOVAL
Authors: ADJEI AA BUDIHARDJO II ROWINSKY EK KOTTKE TJ SVINGEN PA BUCKWALTER CA GROCHOW LB DONEHOWER RC KAUFMANN SH
Citation: Aa. Adjei et al., CYTOTOXIC SYNERGY BETWEEN PYRAZOLOACRIDINE (NSC-366140) AND CISPLATININ-VITRO - INHIBITION OF PLATINUM-DNA ADDUCT REMOVAL, Clinical cancer research, 3(5), 1997, pp. 761-770
PHASE-I AND PHARMACOLOGICAL STUDY OF CI-980, A NOVEL SYNTHETIC ANTIMICROTUBULE AGENT
Authors: ROWINSKY EK LONG GS NOE DA GROCHOW LB BOWLING MK SARTORIUS SE DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF CI-980, A NOVEL SYNTHETIC ANTIMICROTUBULE AGENT, Clinical cancer research, 3(3), 1997, pp. 401-407
PHARMACOLOGY OF CANCER-CHEMOTHERAPY IN THE OLDER PERSON
Authors: BAKER SD GROCHOW LB
Citation: Sd. Baker et Lb. Grochow, PHARMACOLOGY OF CANCER-CHEMOTHERAPY IN THE OLDER PERSON, Clinics in geriatric medicine, 13(1), 1997, pp. 169
PHASE-I AND PHARMACOLOGICAL STUDY OF PENCLOMEDINE, A NOVEL ALKYLATINGAGENT, IN PATIENTS WITH SOLID TUMORS
Authors: OREILLY S GROCHOW LB DONEHOWER RC CHEN TL BOWLING K HARTMAN NR STRUCK RF ROWINSKY EK
Citation: S. Oreilly et al., PHASE-I AND PHARMACOLOGICAL STUDY OF PENCLOMEDINE, A NOVEL ALKYLATINGAGENT, IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 15(5), 1997, pp. 1974-1984
AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF TOPOTECAN
Authors: DENNIS MJ BEIJNEN JH GROCHOW LB VANWARMERDAM LJC
Citation: Mj. Dennis et al., AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF TOPOTECAN, Seminars in oncology, 24(1), 1997, pp. 12-18
NONLINEAR PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER RECEIVING HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION/
Authors: CHEN TL KENNEDY MJ ANDERSON LW KIRALY SB BLACK KC COLVIN OM GROCHOW LB
Citation: Tl. Chen et al., NONLINEAR PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER RECEIVING HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION/, Drug metabolism and disposition, 25(5), 1997, pp. 544-551
LIFE-THREATENING MYELOSUPPRESSION IN PATIENTS WITH OCCULT RENAL IMPAIRMENT RECEIVING TOPOTECAN
Authors: OREILLY S ARMSTRONG DK GROCHOW LB
Citation: S. Oreilly et al., LIFE-THREATENING MYELOSUPPRESSION IN PATIENTS WITH OCCULT RENAL IMPAIRMENT RECEIVING TOPOTECAN, Gynecologic oncology, 67(3), 1997, pp. 329-330
650 CONSECUTIVE PANCREATICODUODENECTOMIES IN THE 1990S - PATHOLOGY, COMPLICATIONS, AND OUTCOMES
Authors: YEO CJ CAMERON JL SOHN TA LILLEMOE KD PITT HA TALAMINI MA HRUBAN RH ORD SE SAUTER PK COLEMAN J ZAHURAK ML GROCHOW LB ABRAMS RA
Citation: Cj. Yeo et al., 650 CONSECUTIVE PANCREATICODUODENECTOMIES IN THE 1990S - PATHOLOGY, COMPLICATIONS, AND OUTCOMES, Annals of surgery, 226(3), 1997, pp. 248-257
PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA - POSTOPERATIVEADJUVANT CHEMORADIATION IMPROVES SURVIVAL - A PROSPECTIVE, SINGLE-INSTITUTION EXPERIENCE
Authors: YEO CJ ABRAMS RA GROCHOW LB SOHN TA ORD SE HRUBAN RH ZAHURAK ML DOOLEY WC COLEMAN J SAUTER PK PITT HA LILLEMOE KD CAMERON JL
Citation: Cj. Yeo et al., PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA - POSTOPERATIVEADJUVANT CHEMORADIATION IMPROVES SURVIVAL - A PROSPECTIVE, SINGLE-INSTITUTION EXPERIENCE, Annals of surgery, 225(5), 1997, pp. 621-633
PHASE-I AND PHARMACOLOGICAL STUDIES OF TOPOTECAN IN PATIENTS WITH IMPAIRED HEPATIC-FUNCTION
Authors: OREILLY S ROWINSKY E SLICHENMYER W DONEHOWER RC FORASTIERE A ETTINGER D CHEN TL SARTORIUS S BOWLING K SMITH J BRUBAKER A LUBEJKO B IGNACIO V GROCHOW LB
Citation: S. Oreilly et al., PHASE-I AND PHARMACOLOGICAL STUDIES OF TOPOTECAN IN PATIENTS WITH IMPAIRED HEPATIC-FUNCTION, Journal of the National Cancer Institute, 88(12), 1996, pp. 817-824
CYTOTOXIC EFFECTS OF TOPOTECAN COMBINED WITH VARIOUS ANTICANCER AGENTS IN HUMAN CANCER CELL-LINES
Authors: KAUFMANN SH PEEREBOOM D BUCKWALTER CA SVINGEN PA GROCHOW LB DONEHOWER RC ROWINSKY EK
Citation: Sh. Kaufmann et al., CYTOTOXIC EFFECTS OF TOPOTECAN COMBINED WITH VARIOUS ANTICANCER AGENTS IN HUMAN CANCER CELL-LINES, Journal of the National Cancer Institute, 88(11), 1996, pp. 734-741
CYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE KINETICS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE CHEMOTHERAPY/
Authors: ANDERSON LW CHEN TL COLVIN OM GROCHOW LB COLLINS JM KENNEDY MJ STRONG JM
Citation: Lw. Anderson et al., CYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE KINETICS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE CHEMOTHERAPY/, Clinical cancer research, 2(9), 1996, pp. 1481-1487
A PHASE-II TRIAL OF TOPOTECAN IN PATIENTS WITH PREVIOUSLY UNTREATED PANCREATIC-CANCER
Authors: OREILLY S DONEHOWER RC ROWINSKY EK ORD S GROCHOW LB
Citation: S. Oreilly et al., A PHASE-II TRIAL OF TOPOTECAN IN PATIENTS WITH PREVIOUSLY UNTREATED PANCREATIC-CANCER, Anti-cancer drugs, 7(4), 1996, pp. 410-414
PHASE-I AND PHARMACOLOGICAL STUDY OF HIGH-DOSES OF THE TOPOISOMERASE-I INHIBITOR TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH SOLID TUMORS
Authors: ROWINSKY EK GROCHOW LB SARTORIUS SE BOWLING MK KAUFMANN SH PEEREBOOM D DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF HIGH-DOSES OF THE TOPOISOMERASE-I INHIBITOR TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 14(4), 1996, pp. 1224-1235
PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
Authors: OREILLY S ROWINSKY EK SLICHENMYER W DONEHOWER RC FORASTIERE AA ETTINGER DS CHEN TL SARTORIUS S GROCHOW LB
Citation: S. Oreilly et al., PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION, Journal of clinical oncology, 14(12), 1996, pp. 3062-3073
SEQUENCES OF TOPOTECAN AND CISPLATIN - PHASE-I, PHARMACOLOGICAL, AND IN-VITRO STUDIES TO EXAMINE SEQUENCE DEPENDENCE
Authors: ROWINSKY EK KAUFMANN SH BAKER SD GROCHOW LB CHEN TL PEEREBOOM D BOWLING MK SARTORIUS SE ETTINGER DS FORASTIERE AA DONEHOWER RC
Citation: Ek. Rowinsky et al., SEQUENCES OF TOPOTECAN AND CISPLATIN - PHASE-I, PHARMACOLOGICAL, AND IN-VITRO STUDIES TO EXAMINE SEQUENCE DEPENDENCE, Journal of clinical oncology, 14(12), 1996, pp. 3074-3084
PHARMACOKINETIC, ORAL BIOAVAILABILITY, AND SAFETY STUDY OF FLUOROURACIL IN PATIENTS TREATED WITH 776C85, AN INACTIVATOR OF DIHYDROPYRIMIDINE DEHYDROGENASE
Authors: BAKER SD KHOR SP ADJEI AA DOUCETTE M SPECTOR T DONEHOWER RC GROCHOW LB SARTORIUS SE NOE DA HOHNEKER JA ROWINSKY EK
Citation: Sd. Baker et al., PHARMACOKINETIC, ORAL BIOAVAILABILITY, AND SAFETY STUDY OF FLUOROURACIL IN PATIENTS TREATED WITH 776C85, AN INACTIVATOR OF DIHYDROPYRIMIDINE DEHYDROGENASE, Journal of clinical oncology, 14(12), 1996, pp. 3085-3096
EARLY EVALUATION OF ABDOMINAL HEPATIC IRRADIATION AND 5-FLUOROURACIL LEUCOVORIN INFUSION AFTER PANCREATICODUODENECTOMY
Authors: CARDUCCI MA ABRAMS RA YEO CJ HRUBAN RH ZAHURAK ML CAMERON JL GROCHOW LB
Citation: Ma. Carducci et al., EARLY EVALUATION OF ABDOMINAL HEPATIC IRRADIATION AND 5-FLUOROURACIL LEUCOVORIN INFUSION AFTER PANCREATICODUODENECTOMY, International journal of radiation oncology, biology, physics, 35(1), 1996, pp. 143-150
Risultati: 1-25 | 26-44